UK markets closed
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • FTSE 250

    19,835.95
    +146.93 (+0.75%)
     
  • AIM

    956.64
    +9.47 (+1.00%)
     
  • GBP/EUR

    1.1822
    +0.0040 (+0.34%)
     
  • GBP/USD

    1.2496
    +0.0021 (+0.17%)
     
  • BTC-GBP

    23,430.12
    -913.85 (-3.75%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • DOW

    31,261.90
    +8.77 (+0.03%)
     
  • CRUDE OIL

    112.70
    +0.49 (+0.44%)
     
  • GOLD FUTURES

    1,845.10
    +3.90 (+0.21%)
     
  • NIKKEI 225

    26,739.03
    +336.19 (+1.27%)
     
  • HANG SENG

    20,717.24
    +596.56 (+2.96%)
     
  • DAX

    13,981.91
    +99.61 (+0.72%)
     
  • CAC 40

    6,285.24
    +12.53 (+0.20%)
     

US Life Sciences Research Tools Growth Opportunities

·1-min read
ReportLinker
ReportLinker

The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e. g. , X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human health.

New York, May 12, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "US Life Sciences Research Tools Growth Opportunities" - https://www.reportlinker.com/p06276194/?utm_source=GNW
The umbrella term applies to several applications, such as genomics, proteomics, and cell biology. The end-user focus is academia. The converging ecosystem includes government, National Institutes of Health (NIH)-funded institutes/organizations (e.g., academic research labs, non-profit research organizations, and hospitals), and private industries. The analysis includes growth in the life sciences industry and the prominent increase in the R&D sector that will significantly enhance the research tools space. The study highlights discussions on scientific trends, government policies, and science spending budget proposals. The growth environment encompasses opportunities in the consumable and technologies market segment. Multi-omics research, artificial intelligence (AI)-based risk prediction and stratification prototypes, and open innovation collaborations present growth opportunities. The analyst finds that the manifesto to launch the ARPA-H in 2022 to drive translational research provides funding opportunities for diabetes, Alzheimer’s disease, cancer, and infectious diseases. The NIH’s new research model, rooted in biological sciences, implies an enlivening change from the traditional funding mechanism and is expected to foster academic collaboration.Major market participants are Roche, Thermo Fisher Scientific, Bio-Rad Laboratories, Bruker, Danaher, GE Healthcare, Illumina, MilliporeSigma, Qiagen, Sartorius Group, Waters, PerkinElmer, Shimadzu, and Luminex (DiaSorin).
Author: Amartya Bose
Read the full report: https://www.reportlinker.com/p06276194/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting